Cite
HARVARD Citation
Di Noia, V. et al. (2019). DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer. Future oncology. pp. 2349-2360. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Di Noia, V. et al. (2019). DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer. Future oncology. pp. 2349-2360. [Online].